Mechanism of RNAi in Genomics and Therapeutics: A Review

نویسندگان

  • Reena Murali
  • Richard A. Jorgensen
  • Paul D. Cluster
  • James English
  • Qiudeng Que
  • Carolyn A. Napoli
  • Jürgen Soutschek
  • Akin Akinc
  • Birgit Bramlage
  • Klaus Charisse
  • Rainer Constien
  • Mary Donoghue
  • Sayda Elbashir
  • Anke Geick
  • Philipp Hadwiger
  • Jens Harborth
  • Matthias John
  • Venkitasamy Kesavan
  • Gary Lavine
  • Rajendra K Pandey
  • Timothy Racie
  • Kallanthottathil G Rajeev
  • Ingo Röhl
  • Ivanka Toudjarska
  • Gang Wang
  • Silvio Wuschko
  • David Bumcrot
  • Victor Koteliansky
  • Stefan Limmer
  • Muthiah Manoharan
  • Hans-Peter Vornlocher
چکیده

RNA interference (RNAi) has the potential to address gene regulatory role in an efficient manner. Short interfering RNA (siRNA), the small RNA deriving from RNAi can control the gene regulation, by a technique called gene silencing. Gene silencing is "switching off" genes which are over expressed, in a sequence specific manner. SiRNA has been experimentally studied in disease therapy and is expected to be developed as a nucleic acid based medicine for incurable diseases such as cancer. This paper reviews the mechanism of RNAi as a gene regulator in genomics and therapeutics.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Artificial intelligence & genetics

Artificial intelligence (AI) is the development of computer systems that are able to perform tasks that normally require human intelligence. Artificial intelligence (AI) is a wide-ranging tool that enables people to rethink how we integrate information, analyze data, and use the resulting insights to improve decision making—and already it is transforming every walk of life. AI has application...

متن کامل

Exploring in vitro roles of siRNA in cardiovascular disease1

RNA interference (RNAi) is an adaptive defense mechanism through which doublestranded RNAs silence cognate genes in a sequence-specific manner. It has been employed widely as a powerful tool in functional genomics studies, target validation and therapeutic product development. Similarly, the application of smallinterfering RNA (siRNA) to the silencing of the disease-causing genes involved in ca...

متن کامل

Development of new RNAi therapeutics.

RNAi-mediated gene inactivation has become a cornerstone of the present day gene function studies that are the foundation of mechanism and target based drug discovery and development, which could potentially shorten the otherwise long process of drug development. In particular, the coming of age of "RNAi drug" could provide new promising therapeutics bypassing traditional approaches. However, t...

متن کامل

p38 MAPK and PI3K/AKT signalling cascades in Parkinson’s disease

Parkinson's disease (PD) is a chronic neurodegenerative condition which has the second largest incidence rate among all other neurodegenerative disorders barring Alzheimer's disease (AD). Currently there is no cure and researchers continue to probe the therapeutic prospect in cell cultures and animal models of PD. Out of several factors contributing to PD prognosis, the role of p38 MAPKs (mitog...

متن کامل

The therapeutic potential of RNA interference.

In recent years, we have witnessed the discovery of a new mechanism of gene regulation called RNA interference (RNAi), which has revitalized interest in the development of nucleic acid-based technologies for therapeutic gene suppression. This review focuses on the potential therapeutic use of RNAi, discussing the theoretical advantages of RNAi-based therapeutics over previous technologies as we...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012